CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.
Assembly language programmers must be aware of hidden side effects — instructions that modify parts of the processor state which are not mentioned in the instruction's mnemonic. A classic example of a hidden side effect is an arithmetic instruction that implicitly modifies condition codes (a hidden side effect) while it explicitly modifies a register (the overt effect). One potential drawback of an instruction set with hidden side effects is that, if many instructions have side effects on a single piece of state, like condition codes, then the logic required to update that state sequentially may become a performance bottleneck. The problem is particularly acute on some processors designed with pipelining (since 1990) or with out-of-order execution . Such a processor may require additional control circuitry to detect hidden side effects and stall the pipeline if the next instruction depends on the results of those effects.
The result of this research strategy is that a good deal is known about the pharmacology of THC, but experimental confirmation that the pharmacology of a marijuana cigarette is indeed entirely or mainly determined by the amount of THC it contains remains to be completed. The scientific literature contains occasional hints that the pharmacology of pure THC, although similar, is not always the same as the clinical pharmacology of smoked marijuana containing the same amount of THC (Graham 1976, Harvey 1985, Institute of Medicine 1982)" (Report to the Director, National Institutes of Health, by the Ad-Hoc Group of Experts, "Workshop on the Medical Utility of Marijuana.")